After finishing at $12.95 in the prior trading day, Herbalife Ltd. (NYSE: HLF) closed at $13.00, up 0.39%. In other words, the price has increased by $+0.05 from its previous closing price. On the day, 2554315 shares were traded. HLF stock price reached its highest trading level at $13.26 during the session, while it also had its lowest trading level at $12.87.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Our goal is to gain a better understanding of HLF by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.87 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 10.63. For the most recent quarter (mrq), Quick Ratio is recorded 0.60 and its Current Ratio is at 1.10.
Upgrades & Downgrades
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 08 when Gratziani Stephan Paulo bought 23,500 shares for $14.06 per share. The transaction valued at 330,300 led to the insider holds 34,529 shares of the business.
Mulligan Donal L bought 15,000 shares of HLF for $289,800 on Feb 22. The Director now owns 30,000 shares after completing the transaction at $19.32 per share. On Feb 21, another insider, L’Helias Sophie, who serves as the Director of the company, bought 8,500 shares for $19.48 each. As a result, the insider paid 165,620 and bolstered with 17,060 shares of the company.
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HLF now has a Market Capitalization of 1.40B and an Enterprise Value of 3.82B. As of this moment, Herbalife’s Price-to-Earnings (P/E) ratio for their current fiscal year is 5.10, and their Forward P/E ratio for the next fiscal year is 3.52. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.25. Its current Enterprise Value per Revenue stands at 0.75 whereas that against EBITDA is 6.40.
Stock Price History:
Over the past 52 weeks, HLF has reached a high of $30.65, while it has fallen to a 52-week low of $12.04. The 50-Day Moving Average of the stock is 15.09, while the 200-Day Moving Average is calculated to be 18.56.
The stock has traded on average 1.22M shares per day over the past 3-months and 1.52M shares per day over the last 10 days, according to various share statistics. A total of 98.50M shares are outstanding, with a floating share count of 96.62M. Insiders hold about 1.50% of the company’s shares, while institutions hold 107.92% stake in the company. Shares short for HLF as of Apr 27, 2023 were 12.83M with a Short Ratio of 12.83M, compared to 11.77M on Mar 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 12.97% and a Short% of Float of 15.05%.
Dividends & Splits
The current Payout Ratio is 0.00% for HLF, which recently paid a dividend on Mar 17, 2014 with an ex-dividend date of Feb 27, 2014. Stock splits for the company last occurred on May 14, 2018 when the company split stock in a 2:1 ratio.
Its stock is currently analyzed by 2 different market analysts. On average, analysts expect EPS of $0.69 for the current quarter, with a high estimate of $0.77 and a low estimate of $0.61, while EPS last year was $0.96. The consensus estimate for the next quarter is $0.77, with high estimates of $0.82 and low estimates of $0.72.
Analysts are recommending an EPS of between $3 and $2.27 for the fiscal current year, implying an average EPS of $2.67. EPS for the following year is $3.7, with 3 analysts recommending between $4 and $3.53.
2 analysts predict $1.26B in revenue for the current quarter. It ranges from a high estimate of $1.27B to a low estimate of $1.26B. As of the current estimate, Herbalife Ltd.’s year-ago sales were $1.39B, an estimated decrease of -9.20% from the year-ago figure. For the next quarter, 2 analysts are estimating revenue of $1.21B, a decrease of -6.70% over than the figure of -$9.20% in the same quarter last year. There is a high estimate of $1.23B for the next quarter, whereas the lowest estimate is $1.19B.
A total of 3 analysts have provided revenue estimates for HLF’s current fiscal year. The highest revenue estimate was $5.03B, while the lowest revenue estimate was $4.79B, resulting in an average revenue estimate of $4.9B. In the same quarter a year ago, actual revenue was $5.2B, down -5.80% from the average estimate. Based on 3 analysts’ estimates, the company’s revenue will be $5.04B in the next fiscal year. The high estimate is $5.18B and the low estimate is $4.94B. The average revenue growth estimate for next year is up 2.70% from the average revenue estimate for this year.